Patent Baristas

The U.S. Supreme Court gave tech businesses what they wanted — more defense against patent suits. The Court made it easier to get a patent declared invalid for failing to show “real innovation” in development. Technology companies, especially software developers, have been beating a never-ending drumbeat that they are the victims of patent suits, therefore […]

Who Doesn’t Want to Save on Heathcare? In a week of thumbing noses at patents, Brazil said it will buy a generic version of a Merck’s efavirenz anti-retroviral drug for the treatment of AIDS unless it offers Brazil a deeper discount on the medicine.  Health Minister Jose Gomes Temporao signed a decree declaring a “public […]

Today is World Intellectual Property Day, a day organized by the World Intellectual Property Organization (WIPO) as a way to encourage people to think about intellectual property in everyday life, and about its importance in protecting IP. April 26 was chosen as this was the date on which the Convention Establishing the World Intellectual Property […]

The big news this week was that biotechnology was the hottest sector in venture capital in the first quarter of this year. A report out Monday by the National Venture Capital Association, which published the study together with PricewaterhouseCoopers based on data from Thomson Financial, showed that investors poured $7.1 billion into 778 deals. Overall, […]

In 2001, AstraZeneca filed suit in the US against against several pharmaceutical companies that were seeking permission from the Food and Drug Administration (FDA) to market generic versions of Prilosec, Astra’s gastric acid inhibiting drug, for infringement of a patent directed to a process for making an omeprazole formulation. Andrx filed counterclaims of non-infringement, invalidity […]

Mylan Laboratories has announced that the U.S. Food and Drug Administration (FDA) has confirmed Mylan’s current status as the only approved ANDA for all strengths of Amlodipine Besylate Tablets. The decision came to light in a filing on Wednesday with the U.S. District Court for the District of Columbia, which had enjoined the FDA from […]

A recent petition for cert addresses the question of what, if any, recourse is available to a patentee against the United States for infringed method claims, where some or all of the method steps are carried out in another country, but the product of that process is imported into the US. In addition, the petition […]

If you or a colleague will be attending BIO 2007 in Boston, we’d like to invite you to join us for a breakfast seminar featuring four of Ohio’s premiere bioscience research institutions.  The breakfast event, entitled “Partnering with Ohio’s World-Class Research Institutions” is scheduled for Monday, May 7 from 7:45am-9:15am at M.J. O’Connor’s Irish Pub, next […]